Arcellx’s $115 Million Series C Financing

Wilson Sonsini Goodrich & Rosati advised Arcellx on the deal.Arcellx, a privately held clinical-stage biopharmaceutical company, announced that it raised $115 million in a Series C…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now